FIRST UNITED BANK & TRUST
BankPosition in TMO — Thermo Fisher Scientific Inc.
CIK 1214183
OAKLAND, MD
Position in TMO
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$54,648
+$1,072 QoQ
Shares Held
109
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#2,420
of 2,606 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FIRST UNITED BANK & TRUST holds $2,166,167 across 7 Diagnostics & Research names. TMO ranks #3 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
8,877 | $1,690,890 | |
| 2 | NEO |
Neogenomics Inc
|
23,000 | $335,570 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
This page
|
109 | $54,648 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
62 | $32,639 | |
| 5 | WAT |
Waters Corp /De/
|
73 | $27,377 | |
| 6 | A |
Agilent Technologies, Inc.
|
100 | $13,283 | |
| 7 | LH |
Labcorp Holdings Inc.
|
42 | $11,760 |
All Filings in TMO
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $54,648 | 109 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $53,576 | 109 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $63,160 | 109 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $52,867 | 109 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $48,249 | 119 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $59,214 | 119 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $61,907 | 119 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $73,609 | 119 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $65,807 | 119 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $69,163 | 119 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $63,164 | 119 | Shares | Sole | 2024-02-08 | |
| No filing history on record for this holder in this stock. | ||||||